EURADIA's ambition is to create the 'Who's Who' of people and groups carrying out clinical and basic research on diabetes in Europe in order to stimulate international collaboration.
Immunodeficiency mutation databases — a new research tool
✍ Scribed by C.I.Edvard Smith; Mauno Vihinen
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 184 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0167-5699
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The tumor suppressor gene TP53 (p53) is the most extensively studied gene involved in human cancers. More than 1,400 publications have reported mutations of this gene in 150 cancer types for a total of 14,971 mutations. To exploit this huge bulk of data, specific analytic tools were highly warranted
Although 20 years have elapsed since the first single basepair substitution underlying an inherited disease in humans was characterised at the DNA level, the initiative has only recently been taken to establish central database resources for pathological genetic variants. Disease-associated gene les
The neuronal voltage-gated sodium channel Na v 1.1 encoded by the SCN1A gene plays an important role in the generation and propagation of action potentials in the central nervous system. Altered function of this channel due to mutations in SCN1A leads to hypersynchronous neuronal discharges resultin
Rett syndrome (RTT) is a neurodevelopmental disorder affecting primarily females, with an incidence of around 1 in 15,000 females. In 1999, mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2) were first reported in RTT subjects, and since that time there have been a number of publica